{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:56:38Z","timestamp":1761562598124,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.carrev.2018.11.004","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T11:36:09Z","timestamp":1541590569000},"page":"739-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes One Year and Beyond After Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stenting During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"20","author":[{"given":"Hui Wen","family":"Sim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H.","family":"Thong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huay Cheem","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian F.","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar L.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poay Huan","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koo Hui","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P.","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2018.11.004_bb0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacc.2007.04.059","article-title":"Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden","volume":"50","author":"Sianos","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.11.004_bb0010","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.107.762047","article-title":"Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study","volume":"118","author":"Nakazawa","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.11.004_bb0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.11.004_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcin.2009.09.015","article-title":"Anti-CD34 antibodies immobilised on the surface of sirolimus-eluting stents enhance stent endothelialisation","volume":"3","author":"Nakazawa","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0025","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2018.11.004_bb0030","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2007.06.029","article-title":"Longterm clinical outcomes with sirolimus-eluting coronary stents. Five-year results of the RAVEL trial","volume":"50","author":"Morice","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.11.004_bb0035","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","volume":"8","author":"Smits","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0040","first-page":"665","article-title":"Correlated microscopic observations of arterial responses to intravascular stenting","volume":"3","author":"Robinson","year":"1989","journal-title":"Scanning Microsc"},{"key":"10.1016\/j.carrev.2018.11.004_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2006.04.026","article-title":"Endothelial progenitor cell mobilisation after percutaneous coronary intervention","volume":"189","author":"Banerjee","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2018.11.004_bb0050","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0142-9612(03)00042-5","article-title":"Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialisation on hybrid vascular tissue","volume":"24","author":"Shirota","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.carrev.2018.11.004_bb0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/ehr196","article-title":"Capture of circulatory endothelial progenitor cells and accelerated re-endothelialisation of a bioengineered stent in human ex vivo shunt and rabbit denudation model","volume":"33","author":"Larsen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2018.11.004_bb0060","first-page":"666","article-title":"Safety and effectiveness of the Genous endothelial progenitor cell-capture stent: follow-up to 5\u202fyears","volume":"25","author":"Pereira-da-Silva","year":"2013","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2018.11.004_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4244\/EIJV6I7A141","article-title":"Clinical results after coronary stenting with the Genous\u2122 bio-engineered R stent\u2122: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry","volume":"6","author":"Silber","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2018.11.004_bb0070","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4244\/EIJV5I6A115","article-title":"Endothelial progenitor cell capture stent implantation in patients with ST-segment elevation acute myocardial infarction: one-year follow-up","volume":"5","author":"Lee","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2018.11.004_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ahj.2007.08.031","article-title":"Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up","volume":"155","author":"Co","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2018.11.004_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCINTERVENTIONS.109.919936","article-title":"Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix","volume":"3","author":"Granada","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jcin.2016.02.052","article-title":"1-Year results of the REMEDEE registry: clinical outcomes after deployment of the abluminal sirolimus-coated bioengineered (COMBO) stent in a multicenter, prospective all-comers registry","volume":"9","author":"Woudstra","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2018.11.004_bb0090","first-page":"31","article-title":"Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome","volume":"90","author":"Kalkman","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0095","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardised definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.11.004_bb0100","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2018.11.004_bb0105","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1161\/hc2301.092122","article-title":"Mobilisation of endothelial progenitor cells in patients with acute myocardial infarction","volume":"103","author":"Shintani","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.11.004_bb0110","first-page":"9","author":"Lee","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0115","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/eurheartj\/ehy275","volume":"39","author":"Saito","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2018.11.004_bb0120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcin.2012.10.018","article-title":"The REMEDEE trial: a randomised comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent","volume":"6","author":"Haude","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0125","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jacc.2013.05.022","article-title":"Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis","volume":"62","author":"Palmerini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.11.004_bb0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcin.2013.09.006","article-title":"The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial","volume":"7","author":"Sabat\u00e9","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/CIRCINTERVENTIONS.113.001440","article-title":"Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trial","volume":"7","author":"R\u00e4ber","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0140","first-page":"385","article-title":"Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V\u00ae everolimus-eluting stents: one-year results from the XIENCE V USA study","volume":"82","author":"Sudhir","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0145","first-page":"352","article-title":"One-year outcome from an all-comers population of patients with ST-segment elevation myocardial infarction treated with biolimus-eluting stent with biodegradable polymer","volume":"85","author":"Tomai","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.11.004_bb0150","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4244\/EIJV7I12A221","article-title":"Dual antiplatelet therapy after myocardial infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database","volume":"7","author":"Latry","year":"2012","journal-title":"EuroIntervention"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918304937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918304937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:14Z","timestamp":1761560174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838918304937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1553838918304937"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2018.11.004","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes One Year and Beyond After Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stenting During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}